Vaccine researchers have developed a strategy aimed at generating broadly cross-reactive antibodies against the influenza virus: embrace the unfamiliar.
(HealthDay)—Officials at the World Health Organization said that the first round of clinical trials of a potential Ebola vaccine made by drug maker GlaxoSmithKline could begin next month.
After AIDS, SARS, avian flu and the coronavirus, now Ebola is in the headlines and sparking panic. AFP asks health historian Patrick Zylberman if the world should fear a pandemic.
(HealthDay)—About one-third of children with viral infections severe enough to land them in the hospital end up with serious complications—such as pneumonia, seizures and brain swelling, a new study finds.
Like the Spanish flu, polio, AIDS, and SARS before it, Ebola has erupted from seemingly nowhere to claim lives and sow fear of a catastrophic global outbreak.
A specialized subset of lung cells can shake flu infection, yet they remain stamped with an inflammatory gene signature that wreaks havoc in the lung, according to a study published in The Journal of Experimental Me ...